Definitive Contract 75N93018C00035
- Not listed
- This is a $599,234 firm fixed price contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) to Celdara Medical, a small business biotechnology company, under the Small Business Innovation Research (SBIR) program. The contract is for research to discover parasite-derived tolerogenic adjuvants, which could potentially be used in new vaccine development. Celdara Medical conducts research and...
- This federal contract award was granted by the National Institute of Allergy and Infectious Diseases (NIAID) to Bioproximity LLC, a for-profit limited liability company, on June 11, 2014. The contract, valued at $43,222.50, is for a firm fixed-price purchase order to provide other functions related to biomarker assessment of helminth (parasitic worm) infections. The contract has a completion date of December 1, 2015 and was not set aside for any specific business designation. Bioproximity LLC is...
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Cellmic, LLC, a small business, in the amount of $224,661.00. The contract is for a TELE-MONITORING FOR INFECTIOUS DISEASES: A REMOTE SYSTEM FOR ASSESSING PATIENT PARAMETERS AND SPECIMEN ANALYSIS project under the SBIR Program Phase I. The contract is a Definitive Contract with a Firm Fixed Price pricing type and has an ultimate completion date of August 29, 2017. The...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $298,596 definitive contract to Sanaria Inc. of Potomac, MD for Research Type Small Business Innovation Research Program Phase I Action. The contract is a firm fixed price award with a period of performance from August 30, 2022 through April 1, 2024. The place of performance is Potomac, MD and the contract has a total small business set aside...
- This is a $299,820.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Biological Mimetics, Inc. for a Phase I Small Business Innovation Research (SBIR) project to develop a CRISPR-based diagnostic test for parasites. The contract is not set aside. Biological Mimetics is a biotechnology firm that conducts research and development on infectious diseases, vaccines, diagnostics, and...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to CFD Research Corporation, a for-profit organization, to perform Phase I SBIR research on a "SMART BIOREACTOR FOR LARGE-SCALE HIGH TITER PHAGE PREPS" project. The contract has a potential value of $299,946.26 and a completion date of August 15, 2022. This SBIR award was not set aside for a specific business...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $216,444 Small Business Innovation Research (SBIR) Phase I contract to Crosslife Technologies Inc., a self-certified small disadvantaged business, to conduct research and development on diagnostics to enable the detection and elimination of malaria and neglected tropical diseases. The contract was awarded under the NIH/CDC SBIR Contract Solicitation PHS...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $224,751 firm-fixed-price contract to Glucosentient Inc., a small business, for the development of a "TELE-MONITORING FOR INFECTIOUS DISEASES: A REMOTE SYSTEM FOR ASSESSING PATIENT PARAMETERS AND SPECIMEN ANALYSIS." The contract, which has an ultimate completion date of August 29, 2017, was set aside for small businesses. Glucosentient, a...
- This is a Phase II SBIR contract award to Biological Mimetics, Inc., a biotechnology firm in Frederick, Maryland, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The $1,498,641 Firm Fixed Price contract is for the development of a CRISPR-based diagnostic test for parasites, with a completion date of September 14, 2028. The contract is set aside for small businesses under the SBIR program, which aims to stimulate technological innovation. Biological...
- This $596,519 fixed-price federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Ampersand Biosciences LLC, a woman-owned small business. The contract is for the development of reagents to support immunologic analysis of non-mammalian and underrepresented mammalian models, such as ferrets and mice, under SBIR Topic 107. This aligns with NIAID's mission to conduct and support research to...
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Celdara Medical, LLC, a small business biotechnology company. The $598,006 Firm Fixed Price contract supports Celdara Medical's research under the Small Business Innovation Research (SBIR) Program Phase I to discover novel helminth (parasitic worm) immunomodulatory proteins for the treatment of autoimmune diseases. The contract was set aside for participation by small businesses. Celdara Medical has received multiple federal contracts and grants from NIH, including for the development of vaccine adjuvants and treatments targeting infectious diseases, cancer, neurological disorders, and other unmet medical needs.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR SMALL BUSINESS INNOVATION RESEARCH (SBIR) CONTRACT PROPOSALS | PHS-2018-1 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Pre-Solicitation 1/2 | 6/29/17, 11:15 AM | |
Identification of Cellular factors that Modulate Production of HIV-1 Envelope Spike | PHS-2018-1 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Award Notice 2/2 | 7/31/18, 10:50 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 7/17/20 | |
| Not listed | Not listed | $598.0k | 7/31/18 |